Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

Todd Neale

September 17, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Yael L. Maxwell

September 02, 2016

News Industry News

In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion

May 29, 2015

News Daily News

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

April 26, 2013

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

Advertisement

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Renal Denervation a Third Option for Hypertension, European Experts Say

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Renal Function Gains Seen in CKD Patients After TAVR

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

TCTMD’s Top 10 Most Popular Stories for May 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content